Following a federal investigation, AstraZeneca (AZN) has agreed to pay $560,000 to hundreds of sales reps who claimed they were paid less than their colleagues due to racial and gender-based discrimination.
The U.S. Department of Labor found the company paid a lower base salary to 23 Hispanic women primary care sales reps compared to others doing the same job, and 295 women specialty care reps were also paid a lower base salary than men who were sales reps. The discrimination, which is prohibited by government contractors under federal law, occurred between October 2015 and September 2016.
Create a display name to comment
This name will appear with your comment